For those at the forefront of science and technology, having an IP attorney who can keep pace is vital. Coming from broad technical backgrounds and research fields, many of our attorneys have postgraduate or doctoral experience, and fuse legal expertise with scientific knowledge and experience in areas relevant to the pharmaceutical field such as:
In addition to a strong pharmaceutical and biopharmaceutical practice we also have a team of experts in both medical and non-medical life sciences and industrial biochemistry.
"Abel + Imray is the best UK patent prosecution firm we have ever worked with for pharmaceutical patents!"Chief Patent Counsel of a US pharmaceutical company
We assist clients all over the world who seeking protection for their IP in Europe, as well as more local European clients who want to obtain IP rights worldwide. This includes universities and research institutions.
Whoever the client, our guidance is always individually tailored.
We have an extensive portfolio of patent prosecution work in the pharmaceutical and biopharmaceutical areas before the European Patent Office, the UK IP Office and all of the major IP offices around the world, including the USPTO. We’re also well versed in handling opposition and appeal proceedings at the European Patent Office through involvement in several high-value cases.
Our team represent some of the leading pharma brands in advising on trade mark protecting in Europe and internationally, and are recognised as a key partner by some in this area.
Another speciality area for our firm is securing Supplementary Protection Certificates (SPCs) in the UK and more widely across Europe. Our clients in particular value the ability of our attorneys to provide country-specific, strategic advice in this specialised and complex area.
We are also adept at running tailored Freedom to Operate (FTO) and due diligence investigations, and so whether you’re a large corporation planning a major acquisition, or an SME seeking partners, we can provide you with the IP analysis you need.
Our advice is always commercially focused and founded on a rigorous understanding of the necessary drug regulatory processes. It therefore gives us great pride to have assisted a number of our pharma clients in successfully bringing their products to market.